ADJUVANT REACTIVITY PREDICTS SURVIVAL IN PATIENTS WITH HIGH-RISK PRIMARY MALIGNANT-MELANOMA TREATED WITH SYSTEMIC BCG

被引：8

作者：

COCHRAN, AJ

BUYSE, ME

LEJEUNE, FJ

MACHER, E

REVUZ, J

RUMKE, P

机构：

[1] UNIV CALIF LOS ANGELES, DEPT SURG, DIV SURG ONCOL, LOS ANGELES, CA 90024 USA

[2] UNIV CALIF LOS ANGELES, DEPT PATHOL, LOS ANGELES, CA 90024 USA

[3] EUROPEAN ORG RES TREATMENT CANC DATA CTR, B-1000 BRUSSELS, BELGIUM

[4] UNIV MUNSTER, HAUT KLIN, D-4400 MUNSTER, FED REP GER

[5] HOP HENRI MONDOR, F-94010 CRETEIL, FRANCE

[6] HET NEDERLANDS KANKER INST, AMSTERDAM, NETHERLANDS

来源：

INTERNATIONAL JOURNAL OF CANCER | 1981年 / 28卷 / 05期

关键词：

D O I：

10.1002/ijc.2910280503

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：543 / 550

页数：8

共 27 条

[1]

BALCH CM, 1979, CANCER, V43, P883, DOI 10.1002/1097-0142(197903)43:3<883::AID-CNCR2820430316>3.0.CO

[2]

2-V

[3] ASSESSMENT OF PROGNOSIS IN CUTANEOUS MALIGNANT-MELANOMA [J].

BARCLAY, TL ;

CROCKETT, DJ ;

EASTWOOD, DS ;

EASTWOOD, J ;

GILES, GR .

BRITISH JOURNAL OF SURGERY, 1977, 64 (01) :54-58

[4] THICKNESS, CROSS-SECTIONAL AREAS AND DEPTH OF INVASION IN PROGNOSIS OF CUTANEOUS MELANOMA [J].

BRESLOW, A .

ANNALS OF SURGERY, 1970, 172 (05) :902-&

[5]

CLARK WH, 1967, ADV BIOL SKIN PIGMEN, V8

[6]

COCHRAN AJ, 1968, LANCET, V2, P1062

[7]

COCHRAN AJ, 1978, MAN CANCER IMMUNITY

[8]

COX DR, 1972, J R STAT SOC B, V34, P187

[9]

Eilber F R, 1970, Cancer, V25, P362, DOI 10.1002/1097-0142(197002)25:2<362::AID-CNCR2820250213>3.0.CO

[10]

2-V

← 1 2 3 →